Delivery Order SPE2DB22D1103-SPE2DB24FTFD8
Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 24,000 units of the pharmaceutical product CREON DR 100S capsules. The $1,301.80 award has a completion date of March 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary contract vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,317.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 36,000 unit capsules of the pharmaceutical product Creon DR 100s. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. In addition, Amerisourcebergen Drug Corp holds an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR. The $2,458.62 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,404.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 units of the pharmaceutical product CREON DR 100s. The contract has a completion date of January 26, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 24,000 units of the pharmaceutical product Creon DR in 100-count capsule bottles. The $8,452.28 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 that serves as the primary...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,128.12 firm fixed price contract is for the supply of 36,000 unit capsules of the drug "CREON DR". The delivery order was issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 24,000 units of CREON DR 100S capsules. The $1,357.76 contract has a completion date of February 1, 2024 and does not contain a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, providing pharmaceutical products and medical supplies to support military treatment programs and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $7,182.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which has an ultimate completion date of April 3, 2024, is for the delivery of 36,000 unit capsules of the medication CREON DR 100s. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,225.46, is a Firm Fixed Price Delivery Order for the provision of 36,000 unit capsules of the drug CREON DR. The contract has an ultimate completion date of October 27, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 36,000 units of CREON DR 100s capsules. The $6,032.32 contract has a completion date of February 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFD8Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, was awarded a $2,343.24 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 units of the prescription drug Creon DR (100 capsules per bottle) with a completion date of February 14, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen holds with DLA to provide a comprehensive range of pharmaceutical products and medical supplies in support of military treatment programs and facilities. The contract has no set-aside designation.
Generated 5/14/24, 12:34 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 2/13/24 |